Avience Biomedicals Limited IPO – GMP, Review, Share Price, Subscription, and Details

1.Avience Biomedicals Limited IPO Overview

The initial public offering (IPO) of Avience Biomedicals Limited is a public issue under the SME board. The subscription window is scheduled to open on Jun 18, 2026 and close on Jun 22, 2026, with the price band fixed at ₹196–208 per equity share.

2.Issue Details at a Glance

3.Bidding, Allotment & Listing Timeline

• Bidding opens: Jun 18, 2026
• Bidding closes: Jun 22, 2026
• Allotment date: TBA
• Listing date: 2026-06-25
• Minimum investment: ₹1,17,600 for 600 shares
• Registrar: Skyline Financial Services Private Ltd
• Official document: Download Avience Biomedicals Limited RHP PDF

4.Avience Biomedicals Limited IPO GMP Today

The grey market premium for Avience Biomedicals Limited is currently ₹100 per share — roughly 48% over the upper price band. GMP is an informal, unregulated indicator of listing-day sentiment; it is not published by any exchange and can change before listing, so treat it as sentiment rather than a forecast.

5.How to Apply for Avience Biomedicals Limited IPO

1. 1Open IPOGMPTracker or use your broker's app or net banking ASBA facility.
2. 2Search for "Avience Biomedicals Limited IPO" and select it from the list of current issues.
3. 3Choose your demat account and enter your bid quantity in multiples of the 600-share lot, at a price within the ₹196–208 band (or bid at cut-off, if eligible).
4. 4Submit the application and approve the UPI mandate request when it arrives — funds stay blocked in your account and are debited only on allotment.

Allotment is expected to be finalised around TBA, with listing tentatively scheduled for 2026-06-25 on BSE and NSE. Once finalised, check your status on the Avience Biomedicals Limited IPO allotment status page.

6.How to Track Subscription & Allotment

• Live subscription: Track QIB, NII and retail bidding on the IPO subscription status page
• Allotment status: Check your application on the IPO allotment status page
• Full IPO details: See dates, lot size, reservation and financials on the Avience Biomedicals Limited IPO page
• More issues: Browse current IPOs, upcoming IPOs and the IPO event calendar

7.Conclusion

Avience Biomedicals Limited opens on Jun 18, 2026 and closes on Jun 22, 2026 at ₹196–208 per share. Read the offer documents in full and consult a qualified adviser before applying — nothing on this page is investment advice.